Dr Jonathan Cole Romney, in Cedar City, UT - General Practice

Dr Jonathan Cole Romney, is a General Practice physician based in Cedar City, Utah. Dr Jonathan Cole Romney is licensed to practice in Utah (license number 9564164-7100) and his current practice location is 965 S Main St, Suite A, Cedar City, Utah. He can be reached at his office (for appointments etc.) via phone at (435) 586-9904.

NPI number for Dr Jonathan Cole Romney is 1568837110 and his current mailing address is 965 S Main St, Suite A, Cedar City, Utah. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1568837110.

Contact Information

	Dr Jonathan Cole Romney,
	965 S Main St, Suite A, Cedar City, UT 84720-4383
	(435) 586-9904
	(435) 586-9648

Physician's Profile

Full Name	Dr Jonathan Cole Romney
Gender	Male
Speciality	General Practice
Location	965 S Main St, Cedar City, Utah
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1568837110
Provider Enumeration Date: 12/08/2015
Last Update Date: 12/08/2015

Medical Identifiers

Medical identifiers for Dr Jonathan Cole Romney such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1568837110	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	9564164-7100 (Utah)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Jonathan Cole Romney is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Jonathan Cole Romney, 965 S Main St, Suite A, Cedar City, UT 84720-4383 Ph: (435) 586-9904	Dr Jonathan Cole Romney, 965 S Main St, Suite A, Cedar City, UT 84720-4383 Ph: (435) 586-9904

News Archive

Researchers identify protein that triggers inflammation in patients with hemorrhage, sepsis

Investigators at The Feinstein Institute for Medical Research have discovered a protein in the human body that can trigger and mediate inflammation in patients suffering from hemorrhage and sepsis. The findings were published in the online version of Nature Medicine on October 6, 2013.

Enrollment in Derma Sciences DSC127 Phase 2 trial in diabetic foot ulcer healing to conclude September end

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.

CytomX closes $70 million Series D financing round

CytomX, a biotechnology company developing Probody™ therapeutics for the treatment of cancer, today announced the closing of a $70 million Series D financing round. The financing was led by Fidelity Management & Research Company with participation from Casdin Capital, Cormorant Asset Management, Deerfield Management, Perceptive Advisors, Redmile Group, Tekla Healthcare Investors and Tekla Life Sciences Investors, Venrock Healthcare Capital Partners, Wellington Management Company and additional undisclosed investors.

Single puncture technique safe and effective in intravascular ultrasound-guided inferior vena cava filter placement

One venous puncture, rather than two, is a safe and effective approach to intravascular ultrasound-guided inferior vena cava filter placement in critically-ill patients, a new study shows.

Study shows that omega-6 fatty acids could protect against premature death

Could omega-6 fatty acids protect you against premature death? The answer is yes, according to a new University of Eastern Finland study. While protecting against death, omega-6 fatty acids also keep cardiovascular diseases at bay.

Dr Jonathan Cole Romney, - General Practice in Cedar City, UT